Simtra BioPharma Solutions (Simtra) will expand its manufacturing campus in Bloomington, Indiana, US, with an aseptic manufacturing and filing facility. The project will enhance the site’s capacity for producing sterile fill/finish and lyophilisation, as well as supporting their clinical-scale production. The company will invest more than $250m in the expansion.
The project has garnered support from local authorities, including the Bloomington Economic Development Corporation (BEDC) and the Indiana Economic Development Corporation (IEDC). The ground-breaking ceremony for the project was held in June 2024. A new clinical line will be added as part of the expansion, which is slated to begin integrating new products by 2025.
The development will equip the Bloomington campus with the necessary infrastructure to manage projects in their initial stages of development. The facility is anticipated to meet good manufacturing practices (GMP) standards by the latter part of 2026. The site is expected to create more than 130 new employment opportunities in the Bloomington area upon its completion.
Location of Simtra’s manufacturing campus The expansion will occur within Simtra’s existing main campus at 927 South Curry Pike in Monroe County, Bloomington. The new building will become a new focal point for the Bloomington site due to its strategic location on a prominent road near the main entrance, enhancing the site’s visibility and accessibility. Simtra BioPharma Solutions’ Blo.